Skip to main content
. 2018 Aug 6;41(10):2136–2146. doi: 10.2337/dc18-0680

Figure 2.

Figure 2

A: LSM (SE) change in HbA1c over time. B: Proportion of patients achieving an HbA1c <7.0 or ≤6.5% (<53 or ≤48 mmol/mol) at weeks 28 and 52. C: LSM (SE) changes in FPG over time. D: LSM (SE) change in 2-h PPG at weeks 28 and 52. E: LSM (SE) changes in weight over time. F: LSM (SE) change in SBP over time. Error bars show SEs or 95% CIs. To convert FPG or 2-h PPG from mmol/L to mg/dL, divide by 0.0555. DAPA, dapagliflozin; ExQW, exenatide QW; PBO, placebo. *P < 0.05, **P < 0.01, ***P < 0.001 vs. ExQW + DAPA (P values at week 52 are nominal).